Publications 2013


248.

Duranton F, Lundin U, Gayrard N, Mischak H, Aparicio M, Mourad G, Daurès J-P, Weinberger KM, Argilés A.
Plasma and Urinary Amino Acid Profiles in CKD Patients Stage 2 to Hemodialysed

Nephrology Dialysis and Transplantation 2013, 28(Suppl1):i53.


View Abstract    Request Reprint 


247.

Metzger J, Mischak H, Manns MP, Lankisch TO.

626 A Combined Bile and Urine Proteomic Test Increases Diagnostic Accuracy of Cholangiocarcinoma in Patients With Biliary Strictures of Unknown Origin

Gastroenterology 2013, 144(5):S-108.


View Abstract    Request Reprint 


246.

Schönemeier B, Metzger J, Rosendahl J, Plentz RR, Wiegand J, Mischak H, Manns MP, Lankisch TO.

820 Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic Pancreatitis.

Gastroenterology 2013, 144(5):S-143.


View Abstract    Request Reprint 


245.

Metzger J, Mischak H, Manns MP, Lankisch TO.

656: A combined bile and urine proteomic test increases diagnostic accuracy of cholangiocarcinoma in patients with biliary strictures of unknown origin

Journal of Hepatology 2013, 58(Suppl1):S267.


View Abstract    Request Reprint 


244.

Berry M, Galinier M, Fournier P, Delmas C, Desmoulin F, Turkieh A, Mischak H, Mullen W, Barutaut M, Caubere C, Butler J, Roncalli J, Alieva MF, Cohen-Solal A, Seronde MF, Escamilla R, Ferrières J, Koukoui F, Smih F, Rouet P.

Proteomics analysis reveals a promising candidate diagnostic biomarker for heart failure

Clinical Chemistry and Laboratory Medicine 2013, 51(11):eA136.


View Abstract    Request Reprint 


243.

Brown CE, Mischak H, Abalat A, Mullen W, Sattar N, McCarthy NS, Hughes AD, Thom S, Mayet J, Stanton A.

PA. 2. Urinary proteomics can be predictive of cardiovascular events

J Hum Hypertens. 2013, 27(10):647.


View Abstract    Request Reprint 


242.

Berry M, Galinier M, Delmas C, Fournier P, Desmoulin F, Barutaut M, Mischak H, Butler J, Smih F, Rouet P.

New heart failure diagnostic and prognostic biomarkers discovered using capillary electrophoresis coupled to mass spectroscopy

Eur Heart J. 2013, 34(Suppl 1):2821.


View Abstract    Request Reprint 


241.
Mermelekas G, Makridakis M, Koeck T, Vlahou A.

Redox proteomics: from residue modifications to putative biomarker identification by gel- and LC-MS-based approaches
E
xpert Rev Proteomics 2013, 10(6):537-49.


View Abstract    Request Reprint 

 

240.
Husi H, Sanchez-Niño MD, Delles C, Mullen W, Vlahou A, Ortiz A, Mischak H.

A combinatorial approach of Proteomics and Systems Biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI
BMC Syst Biol. 2013, 7:110.


View Abstract    Request Reprint 

 

239.
Dissard R, Klein J, Caubet C, Breuil B, Siwy J, Hoffman J, Sicard L, Ducassé L, Rascalou S, Payre B, Buléon M, Mullen W, Mischak H, Tack I, Bascands JL, Buffin-Meyer B, Schanstra JP.

Long Term Metabolic Syndrome Induced by a High Fat High Fructose Diet Leads to Minimal Renal Injury in C57BL/6 Mice

PLoS One 2013, 3;8(10):e76703.


View Abstract    Request Reprint 

 

238.
Neuhaus J, Schiffer E, Siwy J, Mannello F, Horn LC, Stolzenburg JU.

Proteome-based diagnostic and prognostic biomarkers of prostate cancer
Urologe A. 2013, 52(9):1251-5.


View Abstract    Request Reprint 

 

237.
Latosinska A, Frantzi M, Vlahou A, Mischak H.

Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer
Proteomics Clin Appl. 2013, 7(11-12):779-93.


View Abstract    Request Reprint 

 

236.
Klein J, Lacroix C, Caubet C, Siwy J, Zürbig P, Dakna M, Muller F, Breuil B, Stalmach A, Mullen W, Mischak H, Bandin F, Monsarrat B, Bascands JL, Decramer S, Schanstra JP.

Fetal Urinary Peptides to Predict Postnatal Outcome of Renal Disease in Fetuses with Posterior Urethral Valves (PUV)

Sci Transl Med. 2013, 5(198):198ra106.


View Abstract    Request Reprint 

 

235.
Albalat A, Stalmach A, Bitsika V, Siwy J, Schanstra JP, Petropoulos AD, Vlahou A, Jankowski J, Persson F, Rossing P, Jaskolla TW, Mischak H, Husi H.

Improving peptide relative quantification in MALDI-TOF MS for biomarker assessment

Proteomics 2013, 13(20):2967-75.


View Abstract    Request Reprint 

 

234.

Tedesco S, Mullen W, Mischak H, Bradshaw C, Cristobal S.
Shotgun proteomics in blue mussels exposed to benthic trawler-induced sediment resuspension from a polluted fjord
Farm Animal Proteomics 2013, Editors: de Almeida A, Eckersall D, Bencurova E, Dolinska S, Mlynarcik P, Vincova M, Bhide MR, pp.
258–261.


View Abstract    Request Reprint 


233.

Schönemeier B, Metzger J, Rosendahl J, Plentz R, Wiegand J, Mischak H, Manns MP, Lankisch TO.
Die Proteomanalyse im Urin als nicht-invasive Methode zur Detektion von Pankreaskarzinomen
Zeitschrift für Gastroenterologie
2013, 51(8):K216.


View Abstract    Request Reprint 


232.

Lankisch TO, Metzger J, Voigtländer T, Schönemeier B, Mischak H, Manns MP.
Kombinierte Gallensaft- und Urin-Proteom-Analyse zur Diagnose eines Cholangiokarzinoms bei Patienten mit unklaren Gallenwegsprozessen
Zeitschrift für Gastroenterologie
2013, 51(8):K169.


View Abstract    Request Reprint 


231.
Frantzi M, Zoidakis J, Papadopoulos T, Zurbig P, Katafigiotis I, Stravodimos K, Lazaris A, Giannopoulou I, Ploumidis A, Mischak H, Mullen WB, Vlahou A.

IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers
J Proteome Res. 2013, 12(9):3969-79. Epub 2013 Aug 21.


View Abstract    Request Reprint 

 

230.

Albalat A, Bitsika V, Zurbig P, Siwy J, Mullen W.

High-resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS

Methods Mol Biol. 2013, 984:153-65.


View Abstract    Request Reprint 


229.
Neuhaus J, Schiffer E, Wilcke P, Bauer HW, Leung H, Siwy J, Ulrici W, Paasch U, Horn LC, Stolzenburg J.

Seminal Plasma as a Source of Prostate Cancer Peptide Biomarker Candidates for Detection of Indolent and Advanced Disease
PLoS One 2013, 8(6): e67514.


View Abstract    Request Reprint 

 

228.
Klein G, Schanstra JP, Hoffmann J, Mischak H, Siwy J.

Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products
PLoS One 2013, 8(6):e66682.


View Abstract    Request Reprint 


227.
Argilés A, Siwy J, Duranton F, Gayrard N, Dakna M, Lundin U, Osaba L, Delles C, Mourad G, Weinberger KM, Mischak H.

CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis
PLoS One 2013, 8(5):e62837.


View Abstract    Request Reprint 

 

226.

Jankowski V, Schulz A, Kretschmer A, Mischak H, Boehringer F, van der Giet M, Janke D, Schuchardt M, Herwig R, Zidek W, Jankowski J.
The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates

J Mol Med (Berl). 2013, 91(9):1095-107. Epub 2013 May 1.


View Abstract    Request Reprint 

 

225.
Mansor R, Mullen W, Albalat A, Zerefos P, Mischak H, Barrett DC, Biggs A, Eckersall PD.

A peptidomic approach to biomarker discovery for bovine mastitis
J Proteomics 2013, 85:89-98. Epub 2013 Apr 30.


View Abstract    Request Reprint 

 

224.
Stalmach A, Albalat A, Mullen W, Mischak H.

Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications
Electrophoresis 2013, 34(11):1452-64. Epub 2013 May 8. 


View Abstract    Request Reprint 

 

223.

Mischak H, Vlahou A, Ioannidis JP.
Technical aspects and inter-laboratory variability in native peptide profiling: The CE-MS experience

Clin Biochem. 2013, 46(6):432-43. Epub 2012 Oct 4.


View Abstract    Request Reprint 

 

222.
Klein J, Eales J, Zürbig P, Vlahou A, Mischak H, Stevens R.

Proteasix: a tool for automated and large-scale prediction of proteases involved in naturally-occurring peptide generation
Proteomics 2013, 13(7):1077-82. Epub 2013 Feb 26.

         
View
Abstract    Request Reprint 

 

221.
Kistler AD, Serra AL, Siwy J, Poster D, Krauer F, Torres VE, Mrug M, Grantham JJ, Bae KT, Bost JE, Mullen W, Wüthrich RP, Mischak H, Chapman AB.

Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study
PLoS One. 2013, 8(1):e53016. Epub 2013 Jan 10.

         
View
Abstract    Request Reprint 

 

220.
Albalat A, Franke J, Gonzalez J, Mischak H, Zürbig P.

Urinary proteomics based on capillary electrophoresis coupled to mass spectrometry in kidney disease
Methods Mol Biol. 2013;919:203-13.

         
View
Abstract    Request Reprint 

 

219.
Metzger J, Negm AA, Plentz RR, Weismüller TJ, Wedemeyer J, Karlsen TH, Dakna M, Mullen W, Mischak H, Manns MP, Lankisch TO

Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
Gut 2013, 62(1):122-30. Epub 2012 May 12.


View Abstract    Request Reprint 

 

218.
Roscioni SS, de Zeeuw D, Hellemons ME, Mischak H, Zürbig P, Bakker SJ, Gansevoort RT, Reinhard H, Persson F, Lajer M, Rossing P, Heerspink HJ.

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
Diabetologia 2013, 56(2):259-67. Epub 2012 Oct 20.


View Abstract    Request Reprint 


217.
Carty DM, Schiffer E, Delles C
.
Proteomics in hypertension

J Hum Hypertens. 2013, 27(4):211-6. Epub 2012 Aug 9.
 

View
Abstract    Request Reprint